A retrospective study of the use of percutaneous vesselplasty for pathological vertebral compression fractures

• Published in: Journal of cancer research and therapeutics Vol. 17; no. 7; pp. 1725 - 1729
• Main Authors: Chen, Zhijin, Liu, Lin, Wang, Ziyin, Gong, Ju, Xia, Ning, Huang, Wei, Lu, Jian, Wang, Zhongmin
• Format: Journal Article
• Language: English
• Published: India Wolters Kluwer India Pvt. Ltd 01.12.2021; Medknow Publications and Media Pvt. Ltd; Medknow Publications & Media Pvt. Ltd
• Subjects: Bone cancer; Care and treatment; Fractures; Fractures, Compression - etiology; Fractures, Compression - surgery; Humans; Kyphoplasty - methods; Osteoporotic Fractures - surgery; Patient outcomes; Polymethylmethacrylate; Retrospective Studies; Spinal Fractures - etiology; Spinal Fractures - surgery; Spine; Surgery; Treatment Outcome; China; Pathological vertebral compression fractures; spine; vesselplasty
• ISSN: 0973-1482; 1998-4138; 1998-4138
• DOI: 10.4103/jcrt.jcrt_1349_21

Objective and Aims: To assess percutaneous vesselplasty's safety and efficacy in treating pathological vertebral compression fractures (VCFs). Subjects and Methods: This retrospective review covered nine patients with an equal number of symptomatic pathological VCFs treated with vesselplasty. The study assessed the patients' pain scores, subjective conditions, imaging guidance, and incidence of procedure-related complications. Results: The VCFs were at the T4 and L5 spine regions. The procedure success rate was 100%. In 88.89% (8/9) of the examined cases, there was a posterior vertebral body or pedicle involvement or both. Two patients with high thoracic VCFs underwent combined computed tomography and mobile C-arm fluoroscopy guidance. The other patients underwent digital subtraction angiography guidance. The average visual analog scale (VAS) score and the Oswestry Disability Index (ODI) before the treatment were 7.78 ± 0.67 standard deviation (SD) and 75.45 ± 7.55, respectively. The average VAS score and ODI 3 months after the treatment were 2.67 ± 0.50 (SD) and 32.45 ± 6.19 (P < 0.001), respectively. There were no recorded cases of symptomatic cement leakage or other operation-associated complications. Conclusions: Percutaneous vesselplasty appears to be a safe and effective minimally invasive local treatment for pathological VCFs. This approach may offer benefits in improving pain, mobility, and function and minimizing the bone cement leakage rate while providing a safe and effective alternative treatment for pathological VCFs.